Home / Uncategorized / FDA expresses doubts on Xarelto for atrial fibrillation patients

FDA expresses doubts on Xarelto for atrial fibrillation patients

Study of 14,000 patients didn’t clearly show how safe Xarelto was, or if it’s as effective as anticoagulant warfarin

Go here to see the original:
FDA expresses doubts on Xarelto for atrial fibrillation patients

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top